Universal Biosensors, Inc. (UBI.AX)
AUD 0.06
(-1.59%)
AUD 0.06
(-1.59%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 20 Million AUD | -5.74% |
| 2022 | 21.21 Million AUD | 62.05% |
| 2021 | 13.09 Million AUD | 26.44% |
| 2020 | 10.35 Million AUD | -24.56% |
| 2019 | 13.72 Million AUD | -33.12% |
| 2018 | 20.52 Million AUD | 1.46% |
| 2017 | 20.22 Million AUD | -5.49% |
| 2016 | 21.4 Million AUD | -17.02% |
| 2015 | 25.79 Million AUD | 3.61% |
| 2014 | 24.89 Million AUD | 68.64% |
| 2013 | 14.76 Million AUD | -28.1% |
| 2012 | 20.52 Million AUD | 20.17% |
| 2011 | 17.08 Million AUD | -1.34% |
| 2010 | 17.31 Million AUD | -16.69% |
| 2009 | 20.78 Million AUD | 30.19% |
| 2008 | 15.96 Million AUD | 18.28% |
| 2007 | 13.49 Million AUD | 127.82% |
| 2006 | 5.92 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 4.27 Million AUD | -12.93% |
| 2024 Q2 | 5.43 Million AUD | 27.02% |
| 2024 Q3 | 4.62 Million AUD | -14.93% |
| 2023 FY | 20 Million AUD | -5.74% |
| 2023 Q2 | 4.69 Million AUD | -3.16% |
| 2023 Q1 | 4.84 Million AUD | -7.38% |
| 2023 Q3 | 4.77 Million AUD | 1.74% |
| 2023 Q4 | 4.91 Million AUD | 2.96% |
| 2022 Q3 | 5.53 Million AUD | 0.06% |
| 2022 Q4 | 5.23 Million AUD | -5.52% |
| 2022 FY | 21.21 Million AUD | 62.05% |
| 2022 Q1 | 4.91 Million AUD | 5.61% |
| 2022 Q2 | 5.53 Million AUD | 12.62% |
| 2021 Q1 | 2.43 Million AUD | -17.04% |
| 2021 Q3 | 3.41 Million AUD | 32.1% |
| 2021 Q4 | 4.65 Million AUD | 36.07% |
| 2021 Q2 | 2.58 Million AUD | 6.46% |
| 2021 FY | 13.09 Million AUD | 26.44% |
| 2020 Q2 | 2.71 Million AUD | 4.94% |
| 2020 Q3 | 2.11 Million AUD | -22.06% |
| 2020 FY | 10.35 Million AUD | -24.56% |
| 2020 Q1 | 2.58 Million AUD | 5.04% |
| 2020 Q4 | 2.93 Million AUD | 38.41% |
| 2019 Q3 | 2.53 Million AUD | -11.86% |
| 2019 FY | 13.72 Million AUD | -33.12% |
| 2019 Q4 | 2.46 Million AUD | -2.67% |
| 2019 Q2 | 2.87 Million AUD | -20.2% |
| 2019 Q1 | 3.6 Million AUD | -44.98% |
| 2018 FY | 20.52 Million AUD | 1.46% |
| 2018 Q4 | 6.54 Million AUD | 42.88% |
| 2018 Q3 | 4.57 Million AUD | -15.94% |
| 2018 Q2 | 5.44 Million AUD | -12.92% |
| 2018 Q1 | 6.25 Million AUD | 13.04% |
| 2017 Q4 | 5.53 Million AUD | -2.27% |
| 2017 FY | 20.22 Million AUD | -5.49% |
| 2017 Q1 | 4.18 Million AUD | 228.9% |
| 2017 Q2 | 4.59 Million AUD | 9.88% |
| 2017 Q3 | 5.66 Million AUD | 23.26% |
| 2016 Q1 | 6.49 Million AUD | 12.15% |
| 2016 FY | 21.4 Million AUD | -17.02% |
| 2016 Q3 | 5.35 Million AUD | 36.74% |
| 2016 Q2 | 3.91 Million AUD | -39.69% |
| 2016 Q4 | 1.27 Million AUD | -76.26% |
| 2015 Q2 | 6.45 Million AUD | -1.69% |
| 2015 Q4 | 5.78 Million AUD | -11.15% |
| 2015 Q3 | 6.51 Million AUD | 0.96% |
| 2015 Q1 | 6.56 Million AUD | 234.22% |
| 2015 FY | 25.79 Million AUD | 3.61% |
| 2014 Q1 | 6.29 Million AUD | 82.64% |
| 2014 FY | 24.89 Million AUD | 68.64% |
| 2014 Q4 | 1.96 Million AUD | -68.5% |
| 2014 Q3 | 6.23 Million AUD | 4.77% |
| 2014 Q2 | 5.95 Million AUD | -5.48% |
| 2013 Q2 | 4.93 Million AUD | -14.39% |
| 2013 Q1 | 5.76 Million AUD | -9.47% |
| 2013 FY | 14.76 Million AUD | -28.1% |
| 2013 Q4 | 3.44 Million AUD | -38.27% |
| 2013 Q3 | 5.58 Million AUD | 13.18% |
| 2012 Q3 | 5.37 Million AUD | 14.34% |
| 2012 FY | 20.52 Million AUD | 20.17% |
| 2012 Q2 | 4.7 Million AUD | 25.41% |
| 2012 Q1 | 3.74 Million AUD | 0.0% |
| 2012 Q4 | 6.36 Million AUD | 18.44% |
| 2011 Q1 | 3.15 Million AUD | 0.0% |
| 2011 FY | 17.08 Million AUD | -1.34% |
| 2011 Q3 | 4.34 Million AUD | -8.88% |
| 2011 Q2 | 4.77 Million AUD | 51.32% |
| 2010 Q1 | 3.02 Million AUD | 0.0% |
| 2010 Q3 | 3.21 Million AUD | -10.29% |
| 2010 Q2 | 3.58 Million AUD | 18.67% |
| 2010 FY | 17.31 Million AUD | -16.69% |
| 2009 Q3 | 5.22 Million AUD | -4.99% |
| 2009 FY | 20.78 Million AUD | 30.19% |
| 2009 Q2 | 5.49 Million AUD | 24.3% |
| 2009 Q1 | 4.42 Million AUD | 0.0% |
| 2008 FY | 15.96 Million AUD | 18.28% |
| 2007 FY | 13.49 Million AUD | 127.82% |
| 2006 FY | 5.92 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| 4DMedical Limited | 31.48 Million AUD | 36.475% |
| Adherium Limited | 267.7 Thousand AUD | -7371.05% |
| Aroa Biosurgery Limited | 66.09 Million AUD | 69.742% |
| Atomo Diagnostics Limited | 1.6 Million AUD | -1145.342% |
| Anteris Technologies Ltd | 69.14 Million AUD | 71.077% |
| Control Bionics Limited | 9.82 Million AUD | -103.546% |
| CardieX Limited | 16.64 Million AUD | -20.129% |
| Compumedics Limited | 26.88 Million AUD | 25.594% |
| Cochlear Limited | 1.17 Billion AUD | 98.297% |
| CleanSpace Holdings Limited | 11.35 Million AUD | -76.069% |
| Cyclopharm Limited | 13.38 Million AUD | -49.469% |
| EMVision Medical Devices Ltd | 12.83 Million AUD | -55.843% |
| Nova Eye Medical Limited | 23.99 Million AUD | 16.631% |
| HeraMED Limited | 6.78 Million AUD | -194.86% |
| Imricor Medical Systems, Inc. | -1.11 Million AUD | 1892.393% |
| ImpediMed Limited | 28.04 Million AUD | 28.675% |
| InhaleRx Limited | 2.59 Million AUD | -672.051% |
| LBT Innovations Limited | 1.1 Million AUD | -1706.705% |
| Micro-X Limited | 18.76 Million AUD | -6.588% |
| Neurotech International Limited | 8.75 Million AUD | -128.462% |
| OncoSil Medical Limited | 12.03 Million AUD | -66.117% |
| PolyNovo Limited | 34.92 Million AUD | 42.729% |
| Respiri Limited | 8.03 Million AUD | -148.918% |
| SomnoMed Limited | 58.97 Million AUD | 66.086% |
| Uscom Limited | 5.52 Million AUD | -262.32% |
| Visioneering Technologies, Inc. | 9.63 Million AUD | -107.608% |